1.Single-center, open-label, dose-escalation safety, efficacy and pharmacokinetics exploratory clinical trial of XKDCT023 in adult patients with relapsed or refractory diffuse large B-cell lymphoma;
Indications : adult recurrence or refractory diffuse large B cell lymphoma.
2. Single-center, single-arm, dose-escalation safety, efficacy and pharmacokinetic exploratory clinical trial of XKDCT007 in Claudin18.2-positive advanced solid malignancies.
Indications: Claudin18.2-positive advanced solid tumor.
Those interested in participating in the above clinical trials can contact us or the principal investigator. We will conduct a detailed assessment of your condition to determine whether you are suitable for participating in relevant clinical trials The above clinical trials can contact us or the main investigator. We will conduct a detailed evaluation of your condition to determine whether you are suitable to participate in the relevant clinical trials.
Contact Person: Ms. Shen
Tel.: 86-18826107523
Email: life@xkdbio.com
The subject of the email states "participate in clinical trials"
Industry-university-research cooperation is an effective combination of various production factors needed to promote technological innovation. Universities and scientific research institutes are the exporters of knowledge and talents, and they are the creators of the transformation of science and technology into productivity, while enterprises are the main body of technological innovation and implementers of the transformation of science and technology into productivity. The company attaches great importance to industry-university-research cooperation, and has successively carried out cooperation with many domestic universities.
In April 2021, donate funds to Liaocheng University to set up the "First Condor College Students' Innovation and Entrepreneurship Scholarship" to encourage college students to transform and apply new technologies and actively innovate and start businesses.
In June 2021, co-established "Harbin Institute of Technology and First Condor Technology Cell Drug Research and Development Joint Laboratory" with HIT, committed to the research and development of stem cells, immune cells and other cell drugs.
In July 2022, its subsidiary First Condor Life has reached a cooperation with Jinan University to carry out related research on CAR-T cell drugs.
